Status:
COMPLETED
Efficacy of Faviprevir in COVID-19 Treatment
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Faviprevir in COVID-19 treatment
Detailed Description
Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 treatment
Eligibility Criteria
Inclusion
- Patients with covid 19
Exclusion
- Allergy or contraindications to faviprevir
Key Trial Info
Start Date :
April 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2020
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04351295
Start Date
April 20 2020
End Date
September 28 2020
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University, Ainshams University
Tanta, Egypt, 35111